DOW
58
4
TSN
31
3
EMC
56
8
MO
50
2
FITB
55
3
BLK
69
2
CMG
60
3
TSCO
62
2
RRC
50
-5
M
37
6
XOM
60
4
EXR
39
-5
MET
64
7
URI
62
2
CSCO
56
2
V
52
6
PRU
70
8
NWL
50
3
IBM
75
3
PNW
67
-3
DOW
58
4
TSN
31
3
EMC
56
8
MO
50
2
FITB
55
3
BLK
69
2
CMG
60
3
TSCO
62
2
RRC
50
-5
M
37
6
XOM
60
4
EXR
39
-5
MET
64
7
URI
62
2
CSCO
56
2
V
52
6
PRU
70
8
NWL
50
3
IBM
75
3
PNW
67
-3
Financhill
Back

Arcadia Biosciences 10K Form

Buy
52

RKDA
Arcadia Biosciences

Last Price:
2.78
Seasonality Move:
-23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RKDA News And Ratings

See the #1 stock for the next 7 days that we like better than RKDA

RKDA Financial Statistics

Sales & Book Value

Annual Sales: $5.33M
Cash Flow: $-2.46M
Price / Cash Flow: 0
Annual Sales: $8.59
Price / Book: 0.32

Profitability

EPS (TTM): -4.88000
Net Income (TTM): $-6.78M
Gross Margin: $2.03M
Return on Equity: -49.96%
Return on Assets: -32.8%

Arcadia Biosciences Earnings Forecast

Key Arcadia Biosciences Financial Ratios

  • The Gross Profit Margin over the past 12 years for RKDA is 38.09%.
  • The Selling, General & Administrative Expenses for RKDA have been equal to 272.20% of Gross Profit Margin.
  • The Research & Development expenses have been 26.02% of Revenue.
  • The Interest Expense is -0.14% of Operating Income.
  • The Net Earning history of RKDA is -262.31% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Arcadia Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Food Products
Sector: Consumer Staples
Current Symbol: RKDA
CUSIP: 039014
Website: arcadiabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.61
Quick Ratio: 3.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 23.25

RKDA Technical Analysis vs Fundamental Analysis

Buy
52
Arcadia Biosciences (RKDA) is a Buy

Is Arcadia Biosciences a Buy or a Sell?